{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:40:54Z","timestamp":1791222054523,"version":"4.1.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T00:00:00Z","timestamp":1453334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00702-016-1508-7","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T17:34:09Z","timestamp":1453397649000},"page":"389-399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Role of iron in neurodegenerative diseases"],"prefix":"10.1007","volume":"123","author":[{"given":"Kai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Reichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,21]]},"reference":[{"issue":"1","key":"1508_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","volume":"59","author":"PA Adlard","year":"2008","unstructured":"Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie CW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI (2008) Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59(1):43\u201355. doi: 10.1016\/j.neuron.2008.06.018","journal-title":"Neuron"},{"issue":"9","key":"1508_CR2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3174\/ajnr.A3932","volume":"35","author":"AC Apple","year":"2014","unstructured":"Apple AC, Possin KL, Satris G, Johnson E, Lupo JM, Jakary A, Wong K, Kelley DA, Kang GA, Sha SJ, Kramer JH, Geschwind MD, Nelson SJ, Hess CP (2014) Quantitative 7T phase imaging in premanifest Huntington disease. AJNR Am J Neuroradiol 35(9):1707\u20131713. doi: 10.3174\/ajnr.A3932","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"1508_CR3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.23817","volume":"73","author":"S Ayton","year":"2013","unstructured":"Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, Adlard PA, Bush AI, Finkelstein DI (2013) Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol 73(4):554\u2013559. doi: 10.1002\/ana.23817","journal-title":"Ann Neurol"},{"issue":"5319","key":"1508_CR4","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.276.5319.1709","volume":"276","author":"M Babcock","year":"1997","unstructured":"Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276(5319):1709\u20131712","journal-title":"Science"},{"issue":"3","key":"1508_CR5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.neurobiolaging.2014.10.026","volume":"36","author":"O Bar-Am","year":"2015","unstructured":"Bar-Am O, Amit T, Kupershmidt L, Aluf Y, Mechlovich D, Kabha H, Danovitch L, Zurawski VR, Youdim MB, Weinreb O (2015) Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A\/monoamine oxidase-B inhibitor in animal models of Parkinson\u2019s disease and aging. Neurobiol Aging 36(3):1529\u20131542. doi: 10.1016\/j.neurobiolaging.2014.10.026","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1508_CR6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archneur.56.5.569","volume":"56","author":"G Bartzokis","year":"1999","unstructured":"Bartzokis G, Cummings J, Perlman S, Hance DB, Mintz J (1999) Increased basal ganglia iron levels in Huntington disease. Arch Neurol 56(5):569\u2013574","journal-title":"Arch Neurol"},{"issue":"10","key":"1508_CR7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","volume":"32","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis G, Lu PH, Tishler TA, Fong SM, Oluwadara B, Finn JP, Huang D, Bordelon Y, Mintz J, Perlman S (2007) Myelin breakdown and iron changes in Huntington\u2019s disease: pathogenesis and treatment implications. Neurochem Res 32(10):1655\u20131664. doi: 10.1007\/s11064-007-9352-7","journal-title":"Neurochem Res"},{"issue":"10","key":"1508_CR8","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.neurobiolaging.2014.04.019","volume":"35","author":"J Becerril-Ortega","year":"2014","unstructured":"Becerril-Ortega J, Bordji K, Freret T, Rush T, Buisson A (2014) Iron overload accelerates neuronal amyloid-beta production and cognitive impairment in transgenic mice model of Alzheimer\u2019s disease. Neurobiol Aging 35(10):2288\u20132301. doi: 10.1016\/j.neurobiolaging.2014.04.019","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1508_CR9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1212\/WNL.45.1.182","volume":"45","author":"G Becker","year":"1995","unstructured":"Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson\u2019s disease visualized by transcranial color-coded real-time sonography. Neurology 45(1):182\u2013184","journal-title":"Neurology"},{"issue":"3","key":"1508_CR10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuroimage.2006.10.010","volume":"34","author":"S Behnke","year":"2007","unstructured":"Behnke S, Double KL, Duma S, Broe GA, Guenther V, Becker G, Halliday GM (2007) Substantia nigra echomorphology in the healthy very old: correlation with motor slowing. Neuroimage 34(3):1054\u20131059. doi: 10.1016\/j.neuroimage.2006.10.010","journal-title":"Neuroimage"},{"issue":"5326","key":"1508_CR11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1126\/science.277.5326.653","volume":"277","author":"H Beinert","year":"1997","unstructured":"Beinert H, Holm RH, Munck E (1997) Iron-sulfur clusters: nature\u2019s modular, multipurpose structures. Science 277(5326):653\u2013659","journal-title":"Science"},{"issue":"3","key":"1508_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00702-010-0469-5","volume":"118","author":"D Berg","year":"2011","unstructured":"Berg D (2011) Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson\u2019s disease. J Neural Trans 118(3):453\u2013461. doi: 10.1007\/s00702-010-0469-5","journal-title":"J Neural Trans"},{"issue":"8","key":"1508_CR13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s004150170114","volume":"248","author":"D Berg","year":"2001","unstructured":"Berg D, Siefker C, Becker G (2001) Echogenicity of the substantia nigra in Parkinson\u2019s disease and its relation to clinical findings. J Neurol 248(8):684\u2013689","journal-title":"J Neurol"},{"issue":"6","key":"1508_CR14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1212\/WNL.0b013e31829e6fd2","volume":"81","author":"AI Blazejewska","year":"2013","unstructured":"Blazejewska AI, Schwarz ST, Pitiot A, Stephenson MC, Lowe J, Bajaj N, Bowtell RW, Auer DP, Gowland PA (2013) Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI. Neurology 81(6):534\u2013540. doi: 10.1212\/WNL.0b013e31829e6fd2","journal-title":"Neurology"},{"issue":"1","key":"1508_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1471-4159.1995.64010307.x","volume":"64","author":"S Bodovitz","year":"1995","unstructured":"Bodovitz S, Falduto MT, Frail DE, Klein WL (1995) Iron levels modulate alpha-secretase cleavage of amyloid precursor protein. J Neurochem 64(1):307\u2013315","journal-title":"J Neurochem"},{"issue":"3","key":"1508_CR16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/mds.24926","volume":"27","author":"K Boelmans","year":"2012","unstructured":"Boelmans K, Holst B, Hackius M, Finsterbusch J, Gerloff C, Fiehler J, Munchau A (2012) Brain iron deposition fingerprints in Parkinson\u2019s disease and progressive supranuclear palsy. Mov Disord 27(3):421\u2013427. doi: 10.1002\/mds.24926","journal-title":"Mov Disord"},{"issue":"3","key":"1508_CR17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","volume":"3","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer\u2019s disease. Alzheimers Dement 3(3):186\u2013191. doi: 10.1016\/j.jalz.2007.04.381","journal-title":"Alzheimers Dement"},{"issue":"5681","key":"1508_CR18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.1098991","volume":"305","author":"AL Bulteau","year":"2004","unstructured":"Bulteau AL, O\u2019Neill HA, Kennedy MC, Ikeda-Saito M, Isaya G, Szweda LI (2004) Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305(5681):242\u2013245. doi: 10.1126\/science.1098991","journal-title":"Science"},{"key":"1508_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphar.2014.00045","volume":"5","author":"ZI Cabantchik","year":"2014","unstructured":"Cabantchik ZI (2014) Labile iron in cells and body fluids: physiology, pathology, and pharmacology. Front Pharmacol 5:45. doi: 10.3389\/fphar.2014.00045","journal-title":"Front Pharmacol"},{"issue":"1","key":"1508_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuint.2011.05.006","volume":"59","author":"CB Carroll","year":"2011","unstructured":"Carroll CB, Zeissler ML, Chadborn N, Gibson K, Williams G, Zajicek JP, Morrison KE, Hanemann CO (2011) Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson\u2019s disease. Neurochem Int 59(1):73\u201380. doi: 10.1016\/j.neuint.2011.05.006","journal-title":"Neurochem Int"},{"issue":"2","key":"1508_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/biof.1010","volume":"38","author":"RJ Castellani","year":"2012","unstructured":"Castellani RJ, Moreira PI, Perry G, Zhu X (2012) The role of iron as a mediator of oxidative stress in Alzheimer disease. BioFactors 38(2):133\u2013138. doi: 10.1002\/biof.1010","journal-title":"BioFactors"},{"issue":"1","key":"1508_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chemphyslip.2008.09.004","volume":"157","author":"A Catala","year":"2009","unstructured":"Catala A (2009) Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and\/or pathological conditions. Chem Phys Lipids 157(1):1\u201311. doi: 10.1016\/j.chemphyslip.2008.09.004","journal-title":"Chem Phys Lipids"},{"issue":"10","key":"1508_CR23","doi-asserted-by":"crossref","first-page":"e77023","DOI":"10.1371\/journal.pone.0077023","volume":"8","author":"J Chen","year":"2013","unstructured":"Chen J, Marks E, Lai B, Zhang Z, Duce JA, Lam LQ, Volitakis I, Bush AI, Hersch S, Fox JH (2013) Iron accumulates in Huntington\u2019s disease neurons: protection by deferoxamine. PLoS ONE 8(10):e77023. doi: 10.1371\/journal.pone.0077023","journal-title":"PLoS ONE"},{"issue":"1","key":"1508_CR24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jnr.490310111","volume":"31","author":"JR Connor","year":"1992","unstructured":"Connor JR, Menzies SL, St Martin SM, Mufson EJ (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer\u2019s diseased brains. J Neurosci Res 31(1):75\u201383. doi: 10.1002\/jnr.490310111","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"1508_CR25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0304-3940(93)90805-U","volume":"159","author":"JR Connor","year":"1993","unstructured":"Connor JR, Tucker P, Johnson M, Snyder B (1993) Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer\u2019s disease. Neurosci Lett 159(1\u20132):88\u201390","journal-title":"Neurosci Lett"},{"issue":"4","key":"1508_CR26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jnr.490370405","volume":"37","author":"JR Connor","year":"1994","unstructured":"Connor JR, Boeshore KL, Benkovic SA, Menzies SL (1994) Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res 37(4):461\u2013465. doi: 10.1002\/jnr.490370405","journal-title":"J Neurosci Res"},{"issue":"2","key":"1508_CR27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1471-4159.1995.65020717.x","volume":"65","author":"JR Connor","year":"1995","unstructured":"Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P (1995) A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer\u2019s diseased brains. J Neurochem 65(2):717\u2013724","journal-title":"J Neurochem"},{"issue":"8753","key":"1508_CR28","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","volume":"337","author":"DR Crapper McLachlan","year":"1991","unstructured":"Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer\u2019s disease. Lancet 337(8753):1304\u20131308","journal-title":"Lancet"},{"issue":"4","key":"1508_CR29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.neurobiolaging.2013.10.078","volume":"35","author":"AC Crespo","year":"2014","unstructured":"Crespo AC, Silva B, Marques L, Marcelino E, Maruta C, Costa S, Timoteo A, Vilares A, Couto FS, Faustino P, Correia AP, Verdelho A, Porto G, Guerreiro M, Herrero A, Costa C, de Mendonca A, Costa L, Martins M (2014) Genetic and biochemical markers in patients with Alzheimer\u2019s disease support a concerted systemic iron homeostasis dysregulation. Neurobiol Aging 35(4):777\u2013785. doi: 10.1016\/j.neurobiolaging.2013.10.078","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1508_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00702-010-0470-z","volume":"118","author":"RR Crichton","year":"2011","unstructured":"Crichton RR, Dexter DT, Ward RJ (2011) Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm 118(3):301\u2013314. doi: 10.1007\/s00702-010-0470-z","journal-title":"J Neural Transm"},{"issue":"1","key":"1508_CR31","doi-asserted-by":"crossref","first-page":"e15814","DOI":"10.1371\/journal.pone.0015814","volume":"6","author":"P Davies","year":"2011","unstructured":"Davies P, Moualla D, Brown DR (2011) Alpha-synuclein is a cellular ferrireductase. PLoS ONE 6(1):e15814. doi: 10.1371\/journal.pone.0015814","journal-title":"PLoS ONE"},{"issue":"12","key":"1508_CR32","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/sj.emboj.7601735","volume":"26","author":"I Domenico De","year":"2007","unstructured":"De Domenico I, Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J (2007) Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J 26(12):2823\u20132831. doi: 10.1038\/sj.emboj.7601735","journal-title":"EMBO J"},{"issue":"1\u20132","key":"1508_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-510X(96)00203-1","volume":"143","author":"MA Deibel","year":"1996","unstructured":"Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer\u2019s disease: possible relation to oxidative stress. J Neurol Sci 143(1\u20132):137\u2013142","journal-title":"J Neurol Sci"},{"issue":"14","key":"1508_CR34","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","volume":"283","author":"L Devi","year":"2008","unstructured":"Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283(14):9089\u20139100. doi: 10.1074\/jbc.M710012200","journal-title":"J Biol Chem"},{"issue":"2","key":"1508_CR35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos D, Moreau C, Devedjian JC, Kluza J, Petrault M, Laloux C, Jonneaux A, Ryckewaert G, Garcon G, Rouaix N, Duhamel A, Jissendi P, Dujardin K, Auger F, Ravasi L, Hopes L, Grolez G, Firdaus W, Sablonniere B, Strubi-Vuillaume I, Zahr N, Destee A, Corvol JC, Poltl D, Leist M, Rose C, Defebvre L, Marchetti P, Cabantchik ZI, Bordet R (2014) Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid Redox Signal 21(2):195\u2013210. doi: 10.1089\/ars.2013.5593","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"1508_CR36","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem 52(6):1830\u20131836","journal-title":"J Neurochem"},{"issue":"1","key":"1508_CR37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1471-4159.1990.tb08814.x","volume":"55","author":"DT Dexter","year":"1990","unstructured":"Dexter DT, Carayon A, Vidailhet M, Ruberg M, Agid F, Agid Y, Lees AJ, Wells FR, Jenner P, Marsden CD (1990) Decreased ferritin levels in brain in Parkinson\u2019s disease. J Neurochem 55(1):16\u201320","journal-title":"J Neurochem"},{"issue":"2","key":"1508_CR38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00702-010-0531-3","volume":"118","author":"DT Dexter","year":"2011","unstructured":"Dexter DT, Statton SA, Whitmore C, Freinbichler W, Weinberger P, Tipton KF, Della Corte L, Ward RJ, Crichton RR (2011) Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson\u2019s disease after peripheral administration. J Neural Trans 118(2):223\u2013231. doi: 10.1007\/s00702-010-0531-3","journal-title":"J Neural Trans"},{"issue":"Suppl 1","key":"1508_CR39","first-page":"633","volume":"29","author":"DT Dexter","year":"2014","unstructured":"Dexter DT, Martin-Bastida A, Kabba C, Piccini P, Sharp D, Ward R, Newbold R (2014) A pilot 6\u00a0months efficacy and safety study utilising the iron chelator deferiprone in early stage Parkinson\u2019s disease [abstract]. Mov Disord 29(Suppl 1):633","journal-title":"Mov Disord"},{"key":"1508_CR40","author":"DJ Dominguez","year":"2015","unstructured":"Dominguez DJ, Ng AC, Poudel G, Stout JC, Churchyard A, Chua P, Egan GF, Georgiou-Karistianis N (2015) Iron accumulation in the basal ganglia in Huntington\u2019s disease: cross-sectional data from the IMAGE-HD study. J Neurol Neurosurg Psychiatry. doi: 10.1136\/jnnp-2014-310183","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1508_CR41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R, Alzheimer\u2019s Disease Cooperative Study Steering C, Solanezumab Study G (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370(4):311\u2013321. doi: 10.1056\/NEJMoa1312889","journal-title":"N Engl J Med"},{"issue":"5","key":"1508_CR42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384\u2013386. doi: 10.1212\/01.wnl.0000247740.47667.03","journal-title":"Neurology"},{"issue":"95","key":"1508_CR43","doi-asserted-by":"crossref","first-page":"20140165","DOI":"10.1098\/rsif.2014.0165","volume":"11","author":"J Everett","year":"2014","unstructured":"Everett J, Cespedes E, Shelford LR, Exley C, Collingwood JF, Dobson J, van der Laan G, Jenkins CA, Arenholz E, Telling ND (2014) Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer\u2019s disease peptide beta-amyloid (1\u201342). J R Soc Interface 11(95):20140165. doi: 10.1098\/rsif.2014.0165","journal-title":"J R Soc Interface"},{"issue":"2","key":"1508_CR44","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1471-4159.2002.01118.x","volume":"83","author":"BA Faucheux","year":"2002","unstructured":"Faucheux BA, Martin ME, Beaumont C, Hunot S, Hauw JJ, Agid Y, Hirsch EC (2002) Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson\u2019s disease. J Neurochem 83(2):320\u2013330","journal-title":"J Neurochem"},{"issue":"23","key":"1508_CR45","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1111\/j.1742-4658.2006.05537.x","volume":"273","author":"WJ Firdaus","year":"2006","unstructured":"Firdaus WJ, Wyttenbach A, Giuliano P, Kretz-Remy C, Currie RW, Arrigo AP (2006) Huntingtin inclusion bodies are iron-dependent centers of oxidative events. FEBS J 273(23):5428\u20135441. doi: 10.1111\/j.1742-4658.2006.05537.x","journal-title":"FEBS J"},{"issue":"5","key":"1508_CR46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuint.2012.11.015","volume":"62","author":"C Funke","year":"2013","unstructured":"Funke C, Schneider SA, Berg D, Kell DB (2013) Genetics and iron in the systems biology of Parkinson\u2019s disease and some related disorders. Neurochem Int 62(5):637\u2013652. doi: 10.1016\/j.neuint.2012.11.015","journal-title":"Neurochem Int"},{"issue":"10","key":"1508_CR47","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1016\/j.actbio.2012.06.029","volume":"8","author":"M Geppert","year":"2012","unstructured":"Geppert M, Hohnholt MC, Nurnberger S, Dringen R (2012) Ferritin up-regulation and transient ROS production in cultured brain astrocytes after loading with iron oxide nanoparticles. Acta Biomater 8(10):3832\u20133839. doi: 10.1016\/j.actbio.2012.06.029","journal-title":"Acta Biomater"},{"issue":"3","key":"1508_CR48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00702-010-0503-7","volume":"118","author":"G Gille","year":"2011","unstructured":"Gille G, Reichmann H (2011) Iron-dependent functions of mitochondria\u2014relation to neurodegeneration. J Neural Transm 118(3):349\u2013359. doi: 10.1007\/s00702-010-0503-7","journal-title":"J Neural Transm"},{"issue":"Suppl 1","key":"1508_CR49","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1002\/mds.22636","volume":"25","author":"CG Goetz","year":"2010","unstructured":"Goetz CG (2010) New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S104\u2013S109. doi: 10.1002\/mds.22636","journal-title":"Mov Disord"},{"issue":"18","key":"1508_CR50","doi-asserted-by":"crossref","first-page":"16116","DOI":"10.1074\/jbc.M107866200","volume":"277","author":"N Golts","year":"2002","unstructured":"Golts N, Snyder H, Frasier M, Theisler C, Choi P, Wolozin B (2002) Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. J Biol Chem 277(18):16116\u201316123. doi: 10.1074\/jbc.M107866200","journal-title":"J Biol Chem"},{"issue":"3","key":"1508_CR51","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.410310310","volume":"31","author":"PF Good","year":"1992","unstructured":"Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer\u2019s disease: a laser microprobe (LAMMA) study. Ann Neurol 31(3):286\u2013292. doi: 10.1002\/ana.410310310","journal-title":"Ann Neurol"},{"key":"1508_CR52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12883-015-0331-3","volume":"15","author":"G Grolez","year":"2015","unstructured":"Grolez G, Moreau C, Sablonniere B, Garcon G, Devedjian JC, Meguig S, Gele P, Delmaire C, Bordet R, Defebvre L, Cabantchik IZ, Devos D (2015) Ceruloplasmin activity and iron chelation treatment of patients with Parkinson\u2019s disease. BMC Neurol 15:74. doi: 10.1186\/s12883-015-0331-3","journal-title":"BMC Neurol"},{"issue":"2","key":"1508_CR53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2009-1063","volume":"17","author":"C Grossi","year":"2009","unstructured":"Grossi C, Francese S, Casini A, Rosi MC, Luccarini I, Fiorentini A, Gabbiani C, Messori L, Moneti G, Casamenti F (2009) Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 17(2):423\u2013440. doi: 10.3233\/JAD-2009-1063","journal-title":"J Alzheimers Dis"},{"issue":"10 Pt A","key":"1508_CR54","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bbadis.2015.07.017","volume":"1852","author":"C Guerreiro","year":"2015","unstructured":"Guerreiro C, Silva B, Crespo AC, Marques L, Costa S, Timoteo A, Marcelino E, Maruta C, Vilares A, Matos M, Couto FS, Faustino P, Verdelho A, Guerreiro M, Herrero A, Costa C, de Mendonca A, Martins M, Costa L (2015) Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer\u2019s disease patients. Biochim Biophys Acta 1852(10 Pt A):2116\u20132122. doi: 10.1016\/j.bbadis.2015.07.017","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"1508_CR55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuint.2012.12.005","volume":"62","author":"C Guo","year":"2013","unstructured":"Guo C, Wang P, Zhong ML, Wang T, Huang XS, Li JY, Wang ZY (2013a) Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain. Neurochem Int 62(2):165\u2013172. doi: 10.1016\/j.neuint.2012.12.005","journal-title":"Neurochem Int"},{"issue":"2","key":"1508_CR56","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","volume":"34","author":"C Guo","year":"2013","unstructured":"Guo C, Wang T, Zheng W, Shan ZY, Teng WP, Wang ZY (2013b) Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging 34(2):562\u2013575. doi: 10.1016\/j.neurobiolaging.2012.05.009","journal-title":"Neurobiol Aging"},{"issue":"6","key":"1508_CR57","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/mds.21413","volume":"22","author":"A Haehner","year":"2007","unstructured":"Haehner A, Hummel T, Hummel C, Sommer U, Junghanns S, Reichmann H (2007) Olfactory loss may be a first sign of idiopathic Parkinson\u2019s disease. Mov Disord 22(6):839\u2013842. doi: 10.1002\/mds.21413","journal-title":"Mov Disord"},{"issue":"2","key":"1508_CR58","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0169-328X(99)00011-X","volume":"65","author":"TM Hansen","year":"1999","unstructured":"Hansen TM, Nielsen H, Bernth N, Moos T (1999) Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain. Brain Res Mol Brain Res 65(2):186\u2013197","journal-title":"Brain Res Mol Brain Res"},{"issue":"6","key":"1508_CR59","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1039\/C3SC53461H","volume":"5","author":"DJ Hare","year":"2014","unstructured":"Hare DJ, Lei P, Ayton S, Roberts BR, Grimm R, George JL, Bishop DP, Beavis AD, Donovan SJ, McColl G, Volitakis I, Masters CL, Adlard PA, Cherny RA, Bush AI, Finkelstein DI, Doble PA (2014) An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta. Chem Sci 5(6):2160\u20132169. doi: 10.1039\/c3sc53461h","journal-title":"Chem Sci"},{"key":"1508_CR60","author":"N He","year":"2015","unstructured":"He N, Ling H, Ding B, Huang J, Zhang Y, Zhang Z, Liu C, Chen K, Yan F (2015) Region-specific disturbed iron distribution in early idiopathic Parkinson\u2019s disease measured by quantitative susceptibility mapping. Hum Brain Mapp. doi: 10.1002\/hbm.22928","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"1508_CR61","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.abb.2008.02.015","volume":"474","author":"IU Heinemann","year":"2008","unstructured":"Heinemann IU, Jahn M, Jahn D (2008) The biochemistry of heme biosynthesis. Arch Biochem Biophys 474(2):238\u2013251. doi: 10.1016\/j.abb.2008.02.015","journal-title":"Arch Biochem Biophys"},{"issue":"19","key":"1508_CR62","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1093\/hmg\/9.19.2789","volume":"9","author":"P Hilditch-Maguire","year":"2000","unstructured":"Hilditch-Maguire P, Trettel F, Passani LA, Auerbach A, Persichetti F, MacDonald ME (2000) Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet 9(19):2789\u20132797","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1508_CR63","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1046\/j.1471-4159.2003.02236.x","volume":"88","author":"HH Hoepken","year":"2004","unstructured":"Hoepken HH, Korten T, Robinson SR, Dringen R (2004) Iron accumulation, iron-mediated toxicity and altered levels of ferritin and transferrin receptor in cultured astrocytes during incubation with ferric ammonium citrate. J Neurochem 88(5):1194\u20131202","journal-title":"J Neurochem"},{"issue":"Suppl","key":"1508_CR64","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/ana.410320714","volume":"32","author":"P Jenner","year":"1992","unstructured":"Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD (1992) Oxidative stress as a cause of nigral cell death in Parkinson\u2019s disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson\u2019s Disease Research Group. Ann Neurol 32(Suppl):S82\u2013S87","journal-title":"Ann Neurol"},{"issue":"3","key":"1508_CR65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/cr.2010.20","volume":"20","author":"H Jiang","year":"2010","unstructured":"Jiang H, Song N, Xu H, Zhang S, Wang J, Xie J (2010) Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE\/IRP dependent. Cell Res 20(3):345\u2013356. doi: 10.1038\/cr.2010.20","journal-title":"Cell Res"},{"issue":"Pt 1","key":"1508_CR66","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/brain\/awq319","volume":"134","author":"L Jin","year":"2011","unstructured":"Jin L, Wang J, Zhao L, Jin H, Fei G, Zhang Y, Zeng M, Zhong C (2011) Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson\u2019s disease. Brain 134(Pt 1):50\u201358. doi: 10.1093\/brain\/awq319","journal-title":"Brain"},{"issue":"6","key":"1508_CR67","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","volume":"37","author":"D Kaur","year":"2003","unstructured":"Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boonplueang R, Viswanath V, Jacobs R, Yang L, Beal MF, DiMonte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson\u2019s disease. Neuron 37(6):899\u2013909","journal-title":"Neuron"},{"issue":"1","key":"1508_CR68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0300-483X(00)00231-6","volume":"149","author":"JP Kehrer","year":"2000","unstructured":"Kehrer JP (2000) The Haber\u2013Weiss reaction and mechanisms of toxicity. Toxicology 149(1):43\u201350","journal-title":"Toxicology"},{"issue":"24","key":"1508_CR69","doi-asserted-by":"crossref","first-page":"13635","DOI":"10.1073\/pnas.93.24.13635","volume":"93","author":"K Keyer","year":"1996","unstructured":"Keyer K, Imlay JA (1996) Superoxide accelerates DNA damage by elevating free-iron levels. Proc Natl Acad Sci USA 93(24):13635\u201313640","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1508_CR70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0092-8674(93)90046-S","volume":"72","author":"RD Klausner","year":"1993","unstructured":"Klausner RD, Rouault TA, Harford JB (1993) Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72(1):19\u201328","journal-title":"Cell"},{"issue":"6","key":"1508_CR71","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00401-009-0589-x","volume":"118","author":"AH Koeppen","year":"2009","unstructured":"Koeppen AH, Morral JA, Davis AN, Qian J, Petrocine SV, Knutson MD, Gibson WM, Cusack MJ, Li D (2009) The dorsal root ganglion in Friedreich\u2019s ataxia. Acta Neuropathol 118(6):763\u2013776. doi: 10.1007\/s00401-009-0589-x","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1508_CR72","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12311-012-0383-5","volume":"11","author":"AH Koeppen","year":"2012","unstructured":"Koeppen AH, Ramirez RL, Yu D, Collins SE, Qian J, Parsons PJ, Yang KX, Chen Z, Mazurkiewicz JE, Feustel PJ (2012) Friedreich\u2019s ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus. Cerebellum 11(4):845\u2013860. doi: 10.1007\/s12311-012-0383-5","journal-title":"Cerebellum"},{"key":"1508_CR73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2051-5960-1-26","volume":"1","author":"AH Koeppen","year":"2013","unstructured":"Koeppen AH, Kuntzsch EC, Bjork ST, Ramirez RL, Mazurkiewicz JE, Feustel PJ (2013) Friedreich ataxia: metal dysmetabolism in dorsal root ganglia. Acta Neuropathol Commun 1:26. doi: 10.1186\/2051-5960-1-26","journal-title":"Acta Neuropathol Commun"},{"key":"1508_CR74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuroscience.2011.03.040","volume":"189","author":"L Kupershmidt","year":"2011","unstructured":"Kupershmidt L, Weinreb O, Amit T, Mandel S, Bar-Am O, Youdim MB (2011) Novel molecular targets of the neuroprotective\/neurorescue multimodal iron chelating drug M30 in the mouse brain. Neuroscience 189:345\u2013358. doi: 10.1016\/j.neuroscience.2011.03.040","journal-title":"Neuroscience"},{"issue":"2","key":"1508_CR75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.22592","volume":"71","author":"DH Kwon","year":"2012","unstructured":"Kwon DH, Kim JM, Oh SH, Jeong HJ, Park SY, Oh ES, Chi JG, Kim YB, Jeon BS, Cho ZH (2012) Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol 71(2):267\u2013277. doi: 10.1002\/ana.22592","journal-title":"Ann Neurol"},{"issue":"5","key":"1508_CR76","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbamcr.2015.01.021","volume":"1853","author":"DJ Lane","year":"2015","unstructured":"Lane DJ, Merlot AM, Huang ML, Bae DH, Jansson PJ, Sahni S, Kalinowski DS, Richardson DR (2015) Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease. Biochim Biophys Acta 1853(5):1130\u20131144. doi: 10.1016\/j.bbamcr.2015.01.021","journal-title":"Biochim Biophys Acta"},{"issue":"13","key":"1508_CR77","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/mds.26043","volume":"29","author":"S Lehericy","year":"2014","unstructured":"Lehericy S, Bardinet E, Poupon C, Vidailhet M, Francois C (2014) 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson\u2019s disease. Mov Disord 29(13):1574\u20131581. doi: 10.1002\/mds.26043","journal-title":"Mov Disord"},{"issue":"24","key":"1508_CR78","doi-asserted-by":"crossref","first-page":"17791","DOI":"10.1074\/jbc.M113.460253","volume":"288","author":"S Leidgens","year":"2013","unstructured":"Leidgens S, Bullough KZ, Shi H, Li F, Shakoury-Elizeh M, Yabe T, Subramanian P, Hsu E, Natarajan N, Nandal A, Stemmler TL, Philpott CC (2013) Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin. J Biol Chem 288(24):17791\u201317802. doi: 10.1074\/jbc.M113.460253","journal-title":"J Biol Chem"},{"issue":"3","key":"1508_CR79","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbagen.2011.10.016","volume":"1820","author":"DF Leitner","year":"2012","unstructured":"Leitner DF, Connor JR (2012) Functional roles of transferrin in the brain. Biochim Biophys Acta 1820(3):393\u2013402. doi: 10.1016\/j.bbagen.2011.10.016","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1508_CR80","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.parkreldis.2015.05.024","volume":"21","author":"DH Li","year":"2015","unstructured":"Li DH, Zhang LY, Hu YY, Jiang XF, Zhou HY, Yang Q, Kang WY, Liu J, Chen SD (2015) Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson\u2019s disease. Parkinsonism Relat Disord 21(8):923\u2013928. doi: 10.1016\/j.parkreldis.2015.05.024","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"1508_CR81","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bbamcr.2006.05.011","volume":"1763","author":"R Lill","year":"2006","unstructured":"Lill R, Dutkiewicz R, Elsasser HP, Hausmann A, Netz DJ, Pierik AJ, Stehling O, Urzica E, Muhlenhoff U (2006) Mechanisms of iron-sulfur protein maturation in mitochondria, cytosol and nucleus of eukaryotes. Biochim Biophys Acta 1763(7):652\u2013667. doi: 10.1016\/j.bbamcr.2006.05.011","journal-title":"Biochim Biophys Acta"},{"issue":"2\u20133","key":"1508_CR82","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1432-1033.1982.tb06966.x","volume":"128","author":"CI Lin","year":"1982","unstructured":"Lin CI, Gollub EG, Beattie DS (1982) Synthesis of the proteins of complex III of the mitochondrial respiratory chain in heme-deficient cells. Eur J Biochem 128(2\u20133):309\u2013313","journal-title":"Eur J Biochem"},{"issue":"2","key":"1508_CR83","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/ene.12298","volume":"21","author":"A Macerollo","year":"2014","unstructured":"Macerollo A, Perry R, Stamelou M, Batla A, Mazumder AA, Adams ME, Bhatia KP (2014) Susceptibility-weighted imaging changes suggesting brain iron accumulation in Huntington\u2019s disease: an epiphenomenon which causes diagnostic difficulty. Eur J Neurol 21(2):e16\u2013e17. doi: 10.1111\/ene.12298","journal-title":"Eur J Neurol"},{"issue":"7","key":"1508_CR84","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","volume":"9","author":"F Mangialasche","year":"2010","unstructured":"Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer\u2019s disease: clinical trials and drug development. Lancet Neurol 9(7):702\u2013716. doi: 10.1016\/S1474-4422(10)70119-8","journal-title":"Lancet Neurol"},{"key":"1508_CR85","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fphar.2014.00130","volume":"5","author":"A Martelli","year":"2014","unstructured":"Martelli A, Puccio H (2014) Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation. Front Pharmacol 5:130. doi: 10.3389\/fphar.2014.00130","journal-title":"Front Pharmacol"},{"issue":"16 Pt 2","key":"1508_CR86","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000286384.31050.b5","volume":"70","author":"WR Martin","year":"2008","unstructured":"Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70(16 Pt 2):1411\u20131417. doi: 10.1212\/01.wnl.0000286384.31050.b5","journal-title":"Neurology"},{"issue":"3","key":"1508_CR144","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nbd.2009.02.009","volume":"34","author":"PG Mastroberardino","year":"2009","unstructured":"Mastroberardino PG, Hoffman EK, Horowitz MP, Betarbet R, Taylor G, Cheng D, Anderson M (2009) A novel transferrin\/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease. Neurobiol dis 34(3):417\u2013431","journal-title":"Neurobiol dis"},{"key":"1508_CR87","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mito.2015.02.001","volume":"21","author":"NP Mena","year":"2015","unstructured":"Mena NP, Urrutia PJ, Lourido F, Carrasco CM, Nunez MT (2015) Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. Mitochondrion 21:92\u2013105. doi: 10.1016\/j.mito.2015.02.001","journal-title":"Mitochondrion"},{"issue":"3","key":"1508_CR88","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/mds.21227","volume":"22","author":"S Michaeli","year":"2007","unstructured":"Michaeli S, Oz G, Sorce DJ, Garwood M, Ugurbil K, Majestic S, Tuite P (2007) Assessment of brain iron and neuronal integrity in patients with Parkinson\u2019s disease using novel MRI contrasts. Mov Disord 22(3):334\u2013340. doi: 10.1002\/mds.21227","journal-title":"Mov Disord"},{"issue":"8","key":"1508_CR89","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.sleep.2013.03.004","volume":"14","author":"M Miyamoto","year":"2013","unstructured":"Miyamoto M, Miyamoto T (2013) Neuroimaging of rapid eye movement sleep behavior disorder: transcranial ultrasound, single-photon emission computed tomography, and positron emission tomography scan data. Sleep Med 14(8):739\u2013743. doi: 10.1016\/j.sleep.2013.03.004","journal-title":"Sleep Med"},{"issue":"4","key":"1508_CR90","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/(SICI)1096-9861(19961125)375:4<675::AID-CNE8>3.0.CO;2-Z","volume":"375","author":"T Moos","year":"1996","unstructured":"Moos T (1996) Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J Comp Neurol 375(4):675\u2013692. doi: 10.1002\/(SICI)1096-9861(19961125)375:4<675:AID-CNE8>3.0.CO;2-Z","journal-title":"J Comp Neurol"},{"issue":"1","key":"1508_CR91","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1471-4159.2003.02142.x","volume":"88","author":"T Moos","year":"2004","unstructured":"Moos T, Morgan EH (2004) The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. J Neurochem 88(1):233\u2013245","journal-title":"J Neurochem"},{"issue":"3","key":"1508_CR92","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.spen.2006.08.003","volume":"13","author":"T Moos","year":"2006","unstructured":"Moos T, Rosengren Nielsen T (2006) Ferroportin in the postnatal rat brain: implications for axonal transport and neuronal export of iron. Semin Pediatr Neurol 13(3):149\u2013157. doi: 10.1016\/j.spen.2006.08.003","journal-title":"Semin Pediatr Neurol"},{"issue":"3","key":"1508_CR93","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/(SICI)1096-9861(19980831)398:3<420::AID-CNE8>3.0.CO;2-1","volume":"398","author":"T Moos","year":"1998","unstructured":"Moos T, Oates PS, Morgan EH (1998) Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency. J Comp Neurol 398(3):420\u2013430","journal-title":"J Comp Neurol"},{"issue":"6","key":"1508_CR94","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1471-4159.2006.04023.x","volume":"98","author":"T Moos","year":"2006","unstructured":"Moos T, Skjoerringe T, Gosk S, Morgan EH (2006) Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J Neurochem 98(6):1946\u20131958. doi: 10.1111\/j.1471-4159.2006.04023.x","journal-title":"J Neurochem"},{"issue":"3","key":"1508_CR95","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jnc.12739","volume":"130","author":"M Muller","year":"2014","unstructured":"Muller M, Leavitt BR (2014) Iron dysregulation in Huntington\u2019s disease. J Neurochem 130(3):328\u2013350. doi: 10.1111\/jnc.12739","journal-title":"J Neurochem"},{"issue":"3\u20134","key":"1508_CR96","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0891-0618(00)00096-X","volume":"20","author":"G Munch","year":"2000","unstructured":"Munch G, Luth HJ, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P (2000) Crosslinking of alpha-synuclein by advanced glycation endproducts\u2014an early pathophysiological step in Lewy body formation? J Chem Neuroanat 20(3\u20134):253\u2013257","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"1508_CR97","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cmet.2009.06.012","volume":"10","author":"R Nilsson","year":"2009","unstructured":"Nilsson R, Schultz IJ, Pierce EL, Soltis KA, Naranuntarat A, Ward DM, Baughman JM, Paradkar PN, Kingsley PD, Culotta VC, Kaplan J, Palis J, Paw BH, Mootha VK (2009) Discovery of genes essential for heme biosynthesis through large-scale gene expression analysis. Cell Metab 10(2):119\u2013130. doi: 10.1016\/j.cmet.2009.06.012","journal-title":"Cell Metab"},{"key":"1508_CR98","author":"R Ortega","year":"2015","unstructured":"Ortega R, Carmona A, Roudeau S, Perrin L, Ducic T, Carboni E, Bohic S, Cloetens P, Lingor P (2015) Alpha-synuclein over-expression induces increased iron accumulation and redistribution in iron-exposed neurons. Mol Neurobiol. doi: 10.1007\/s12035-015-9146-x","journal-title":"Mol Neurobiol"},{"issue":"16","key":"1508_CR99","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000","volume":"20","author":"N Ostrerova-Golts","year":"2000","unstructured":"Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B (2000) The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci 20(16):6048\u20136054","journal-title":"J Neurosci"},{"issue":"4","key":"1508_CR100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ana.24248","volume":"76","author":"M Pandolfo","year":"2014","unstructured":"Pandolfo M, Arpa J, Delatycki MB, Le Quan Sang KH, Mariotti C, Munnich A, Sanz-Gallego I, Tai G, Tarnopolsky MA, Taroni F, Spino M, Tricta F (2014) Deferiprone in Friedreich ataxia: a 6-month randomized controlled trial. Ann Neurol 76(4):509\u2013521. doi: 10.1002\/ana.24248","journal-title":"Ann Neurol"},{"issue":"6","key":"1508_CR101","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.44.6.1090","volume":"44","author":"WD Parker Jr","year":"1994","unstructured":"Parker WD Jr, Parks J, Filley CM, Kleinschmidt-DeMasters BK (1994) Electron transport chain defects in Alzheimer\u2019s disease brain. Neurology 44(6):1090\u20131096","journal-title":"Neurology"},{"issue":"8","key":"1508_CR102","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.bbadis.2013.04.007","volume":"1832","author":"I Pelizzoni","year":"2013","unstructured":"Pelizzoni I, Zacchetti D, Campanella A, Grohovaz F, Codazzi F (2013) Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden. Biochim Biophys Acta 1832(8):1326\u20131333. doi: 10.1016\/j.bbadis.2013.04.007","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1508_CR103","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.26218","volume":"30","author":"N Pyatigorskaya","year":"2015","unstructured":"Pyatigorskaya N, Sharman M, Corvol JC, Valabregue R, Yahia-Cherif L, Poupon F, Cormier-Dequaire F, Siebner H, Klebe S, Vidailhet M, Brice A, Lehericy S (2015) High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry. Mov Disord 30(8):1077\u20131084. doi: 10.1002\/mds.26218","journal-title":"Mov Disord"},{"key":"1508_CR104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/2051-5960-1-55","volume":"1","author":"AA Raha","year":"2013","unstructured":"Raha AA, Vaishnav RA, Friedland RP, Bomford A, Raha-Chowdhury R (2013) The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer\u2019s disease. Acta Neuropathol Commun 1:55. doi: 10.1186\/2051-5960-1-55","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"1508_CR105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/glia.22303","volume":"60","author":"KI Rathore","year":"2012","unstructured":"Rathore KI, Redensek A, David S (2012) Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1. Glia 60(5):738\u2013750. doi: 10.1002\/glia.22303","journal-title":"Glia"},{"issue":"2","key":"1508_CR106","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.1989.tb09150.x","volume":"52","author":"P Riederer","year":"1989","unstructured":"Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52(2):515\u2013520","journal-title":"J Neurochem"},{"issue":"47","key":"1508_CR107","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","volume":"277","author":"JT Rogers","year":"2002","unstructured":"Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR (2002) An iron-responsive element type II in the 5\u2032-untranslated region of the Alzheimer\u2019s amyloid precursor protein transcript. J Biol Chem 277(47):45518\u201345528. doi: 10.1074\/jbc.M207435200","journal-title":"J Biol Chem"},{"issue":"4","key":"1508_CR108","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.clinimag.2013.02.001","volume":"37","author":"M Rossi","year":"2013","unstructured":"Rossi M, Ruottinen H, Soimakallio S, Elovaara I, Dastidar P (2013) Clinical MRI for iron detection in Parkinson\u2019s disease. Clin Imaging 37(4):631\u2013636. doi: 10.1016\/j.clinimag.2013.02.001","journal-title":"Clin Imaging"},{"issue":"2","key":"1508_CR109","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","volume":"17","author":"A Rotig","year":"1997","unstructured":"Rotig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P (1997) Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 17(2):215\u2013217. doi: 10.1038\/ng1097-215","journal-title":"Nat Genet"},{"issue":"8","key":"1508_CR110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nchembio807","volume":"2","author":"TA Rouault","year":"2006","unstructured":"Rouault TA (2006) The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2(8):406\u2013414. doi: 10.1038\/nchembio807","journal-title":"Nat Chem Biol"},{"issue":"47","key":"1508_CR111","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.0804373105","volume":"105","author":"J Salazar","year":"2008","unstructured":"Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, Duyckaerts C, Sazdovitch V, Zhao L, Garrick LM, Nunez MT, Garrick MD, Raisman-Vozari R, Hirsch EC (2008) Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson\u2019s disease. Proc Natl Acad Sci USA 105(47):18578\u201318583. doi: 10.1073\/pnas.0804373105","journal-title":"Proc Natl Acad Sci USA"},{"key":"1508_CR112","author":"M Salkovic-Petrisic","year":"2015","unstructured":"Salkovic-Petrisic M, Knezovic A, Osmanovic-Barilar J, Smailovic U, Trkulja V, Riederer P, Amit T, Mandel S, Youdim MB (2015) Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer\u2019s disease. Life Sci. doi: 10.1016\/j.lfs.2015.06.026","journal-title":"Life Sci"},{"issue":"4","key":"1508_CR113","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR, Bapineuzumab, Clinical Trial I (2014) Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370(4):322\u2013333. doi: 10.1056\/NEJMoa1304839","journal-title":"N Engl J Med"},{"issue":"1","key":"1508_CR114","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/hbm.22612","volume":"36","author":"C Sanchez-Castaneda","year":"2015","unstructured":"Sanchez-Castaneda C, Squitieri F, Di Paola M, Dayan M, Petrollini M, Sabatini U (2015) The role of iron in gray matter degeneration in Huntington\u2019s disease: a magnetic resonance imaging study. Hum Brain Mapp 36(1):50\u201366. doi: 10.1002\/hbm.22612","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"1508_CR115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","volume":"74","author":"LM Sayre","year":"2000","unstructured":"Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease: a central role for bound transition metals. J Neurochem 74(1):270\u2013279","journal-title":"J Neurochem"},{"issue":"2","key":"1508_CR116","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2003.09.005","volume":"46","author":"DB Shachar","year":"2004","unstructured":"Shachar DB, Kahana N, Kampel V, Warshawsky A, Youdim MB (2004) Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology 46(2):254\u2013263","journal-title":"Neuropharmacology"},{"issue":"8","key":"1508_CR117","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/nar\/gkp100","volume":"37","author":"I Shokolenko","year":"2009","unstructured":"Shokolenko I, Venediktova N, Bochkareva A, Wilson GL, Alexeyev MF (2009) Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res 37(8):2539\u20132548. doi: 10.1093\/nar\/gkp100","journal-title":"Nucleic Acids Res"},{"issue":"5A","key":"1508_CR118","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1582-4934.2008.00356.x","volume":"12","author":"L Silvestri","year":"2008","unstructured":"Silvestri L, Camaschella C (2008) A potential pathogenetic role of iron in Alzheimer\u2019s disease. J Cell Mol Med 12(5A):1548\u20131550. doi: 10.1111\/j.1582-4934.2008.00356.x","journal-title":"J Cell Mol Med"},{"issue":"2","key":"1508_CR119","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood-2007-07-100677","volume":"111","author":"L Silvestri","year":"2008","unstructured":"Silvestri L, Pagani A, Camaschella C (2008) Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111(2):924\u2013931. doi: 10.1182\/blood-2007-07-100677","journal-title":"Blood"},{"key":"1508_CR120","first-page":"19","volume":"8","author":"T Skjorringe","year":"2015","unstructured":"Skjorringe T, Burkhart A, Johnsen KB, Moos T (2015) Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology. Front Mol Neurosci 8:19. doi: 10.3389\/fnmol.2015.00019","journal-title":"Front Mol Neurosci"},{"issue":"5","key":"1508_CR121","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1046\/j.1471-4159.1998.70052212.x","volume":"70","author":"MA Smith","year":"1998","unstructured":"Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL, Siedlak SL, Tabaton M, Perry G (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70(5):2212\u20132215","journal-title":"J Neurochem"},{"issue":"2","key":"1508_CR122","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.freeradbiomed.2009.11.004","volume":"48","author":"N Song","year":"2010","unstructured":"Song N, Wang J, Jiang H, Xie J (2010) Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson\u2019s disease. Free Radic Biol Med 48(2):332\u2013341. doi: 10.1016\/j.freeradbiomed.2009.11.004","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"1508_CR123","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1080\/10715760600918142","volume":"40","author":"ER Stadtman","year":"2006","unstructured":"Stadtman ER (2006) Protein oxidation and aging. Free Radic Res 40(12):1250\u20131258. doi: 10.1080\/10715760600918142","journal-title":"Free Radic Res"},{"issue":"6","key":"1508_CR124","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1471-4159.2008.05678.x","volume":"107","author":"B Todorich","year":"2008","unstructured":"Todorich B, Zhang X, Slagle-Webb B, Seaman WE, Connor JR (2008) Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem 107(6):1495\u20131505. doi: 10.1111\/j.1471-4159.2008.05678.x","journal-title":"J Neurochem"},{"issue":"4","key":"1508_CR125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00415-006-0403-9","volume":"254","author":"CF Tsai","year":"2007","unstructured":"Tsai CF, Wu RM, Huang YW, Chen LL, Yip PK, Jeng JS (2007) Transcranial color-coded sonography helps differentiation between idiopathic Parkinson\u2019s disease and vascular parkinsonism. J Neurol 254(4):501\u2013507. doi: 10.1007\/s00415-006-0403-9","journal-title":"J Neurol"},{"key":"1508_CR126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fphar.2014.00038","volume":"5","author":"PJ Urrutia","year":"2014","unstructured":"Urrutia PJ, Mena NP, Nunez MT (2014) The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders. Front Pharmacol 5:38. doi: 10.3389\/fphar.2014.00038","journal-title":"Front Pharmacol"},{"issue":"1","key":"1508_CR127","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2014.07.006","volume":"36","author":"S Rooden van","year":"2015","unstructured":"van Rooden S, Doan NT, Versluis MJ, Goos JD, Webb AG, Oleksik AM, van der Flier WM, Scheltens P, Barkhof F, Weverling-Rynsburger AW, Blauw GJ, Reiber JH, van Buchem MA, Milles J, van der Grond J (2015) 7T T(2)*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer\u2019s disease. Neurobiol Aging 36(1):20\u201326. doi: 10.1016\/j.neurobiolaging.2014.07.006","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1508_CR128","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1023\/B:PHAM.0000026425.69874.8e","volume":"21","author":"CC Visser","year":"2004","unstructured":"Visser CC, Voorwinden LH, Crommelin DJ, Danhof M, de Boer AG (2004) Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharm Res 21(5):761\u2013769","journal-title":"Pharm Res"},{"issue":"1","key":"1508_CR129","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2010.10.707","volume":"50","author":"L Wan","year":"2011","unstructured":"Wan L, Nie G, Zhang J, Luo Y, Zhang P, Zhang Z, Zhao B (2011) beta-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radic Biol Med 50(1):122\u2013129. doi: 10.1016\/j.freeradbiomed.2010.10.707","journal-title":"Free Radic Biol Med"},{"issue":"49","key":"1508_CR130","doi-asserted-by":"crossref","first-page":"19318","DOI":"10.1073\/pnas.0804871105","volume":"105","author":"X Wang","year":"2008","unstructured":"Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins. Proc Natl Acad Sci USA 105(49):19318\u201319323. doi: 10.1073\/pnas.0804871105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1508_CR131","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045\u20131060. doi: 10.1016\/S1474-4422(14)70117-6","journal-title":"Lancet Neurol"},{"issue":"5","key":"1508_CR132","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2307\/3579270","volume":"145","author":"P Wardman","year":"1996","unstructured":"Wardman P, Candeias LP (1996) Fenton chemistry: an introduction. Radiat Res 145(5):523\u2013531","journal-title":"Radiat Res"},{"issue":"3","key":"1508_CR133","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.parkreldis.2014.11.017","volume":"21","author":"M Wieler","year":"2015","unstructured":"Wieler M, Gee M, Martin WR (2015) Longitudinal midbrain changes in early Parkinson\u2019s disease: iron content estimated from R2*\/MRI. Parkinsonism Relat Disord 21(3):179\u2013183. doi: 10.1016\/j.parkreldis.2014.11.017","journal-title":"Parkinsonism Relat Disord"},{"key":"1508_CR134","first-page":"81","volume":"5","author":"BX Wong","year":"2014","unstructured":"Wong BX, Duce JA (2014) The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders. Front Pharmacol 5:81. doi: 10.3389\/fphar.2014.00081","journal-title":"Front Pharmacol"},{"issue":"5","key":"1508_CR135","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.2002.t01-1-01061.x","volume":"82","author":"A Yamamoto","year":"2002","unstructured":"Yamamoto A, Shin RW, Hasegawa K, Naiki H, Sato H, Yoshimasu F, Kitamoto T (2002) Iron(III) induces aggregation of hyperphosphorylated \u03c4 and its reduction to iron(II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer\u2019s disease. J Neurochem 82(5):1137\u20131147","journal-title":"J Neurochem"},{"issue":"6","key":"1508_CR136","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1046\/j.1471-4159.2001.00186.x","volume":"76","author":"L Zecca","year":"2001","unstructured":"Zecca L, Gallorini M, Schunemann V, Trautwein AX, Gerlach M, Riederer P, Vezzoni P, Tampellini D (2001) Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes. J Neurochem 76(6):1766\u20131773","journal-title":"J Neurochem"},{"issue":"3","key":"1508_CR137","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","volume":"510","author":"L Zecca","year":"2002","unstructured":"Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson\u2019s disease. FEBS Lett 510(3):216\u2013220","journal-title":"FEBS Lett"},{"issue":"10","key":"1508_CR138","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/mds.20550","volume":"20","author":"L Zecca","year":"2005","unstructured":"Zecca L, Berg D, Arzberger T, Ruprecht P, Rausch WD, Musicco M, Tampellini D, Riederer P, Gerlach M, Becker G (2005) In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20(10):1278\u20131285. doi: 10.1002\/mds.20550","journal-title":"Mov Disord"},{"issue":"9","key":"1508_CR139","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/j.neurobiolaging.2015.05.022","volume":"36","author":"MM Zeineh","year":"2015","unstructured":"Zeineh MM, Chen Y, Kitzler HH, Hammond R, Vogel H, Rutt BK (2015) Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiol Aging 36(9):2483\u20132500. doi: 10.1016\/j.neurobiolaging.2015.05.022","journal-title":"Neurobiol Aging"},{"issue":"6677","key":"1508_CR140","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/33612","volume":"392","author":"Z Zhang","year":"1998","unstructured":"Zhang Z, Huang L, Shulmeister VM, Chi YI, Kim KK, Hung LW, Crofts AR, Berry EA, Kim SH (1998) Electron transfer by domain movement in cytochrome bc1. Nature 392(6677):677\u2013684. doi: 10.1038\/33612","journal-title":"Nature"},{"issue":"12","key":"1508_CR141","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1096\/fj.09-135749","volume":"23","author":"W Zheng","year":"2009","unstructured":"Zheng W, Xin N, Chi ZH, Zhao BL, Zhang J, Li JY, Wang ZY (2009) Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation. FASEB J 23(12):4207\u20134217. doi: 10.1096\/fj.09-135749","journal-title":"FASEB J"},{"issue":"1","key":"1508_CR142","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12640-013-9435-y","volume":"25","author":"FA Zucca","year":"2014","unstructured":"Zucca FA, Basso E, Cupaioli FA, Ferrari E, Sulzer D, Casella L, Zecca L (2014) Neuromelanin of the human substantia nigra: an update. Neurotox Res 25(1):13\u201323. doi: 10.1007\/s12640-013-9435-y","journal-title":"Neurotox Res"},{"key":"1508_CR143","author":"FA Zucca","year":"2015","unstructured":"Zucca FA, Segura-Aguilar J, Ferrari E, Munoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L (2015) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson\u2019s disease. Prog Neurobiol. doi: 10.1016\/j.pneurobio.2015.09.012","journal-title":"Prog Neurobiol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-016-1508-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-016-1508-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-016-1508-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T22:28:54Z","timestamp":1718317734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-016-1508-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,21]]},"references-count":144,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1508"],"URL":"https:\/\/doi.org\/10.1007\/s00702-016-1508-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,21]]}}}